• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例由该基因中一个新的51个碱基对的框内杂合缺失导致的儿童低磷酸酯酶症的独特病例。

A unique case of childhood hypophosphatasia caused by a novel heterozygous 51-bp in-frame deletion in the gene.

作者信息

Tachikawa Kanako, Yamazaki Miwa, Michigami Toshimi

机构信息

Department of Bone and Mineral Research, Research Institute, Osaka Women's and Children's Hospital, Osaka Prefectural Hospital Organization, Osaka, Japan.

出版信息

Clin Pediatr Endocrinol. 2023;32(3):180-187. doi: 10.1297/cpe.2023-0019. Epub 2023 May 6.

DOI:10.1297/cpe.2023-0019
PMID:37362163
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10288296/
Abstract

Hypophosphatasia (HPP) is caused by inactivating variants of the gene, which encodes tissue non-specific alkaline phosphatase (TNSALP). Among the six subtypes of HPP, childhood HPP presents after 6 months and before 18 yr of age, and is inherited in both autosomal dominant and autosomal recessive manners. Patients with childhood HPP have variable symptoms, including rickets-like bone changes, low bone mineral density (BMD), short stature, muscle weakness, craniosynostosis, and premature loss of deciduous teeth. Here, we describe a 7-yr-old boy with childhood HPP who showed short stature, impaired ossification of the carpal bones, and low BMD. Genetic testing identified a novel heterozygous 51-bp in-frame deletion in the gene (c.1482_1532del51), leading to the lack of 17 amino acids between Gly495 and Leu511 (p.Gly495_Leu511del). transfection experiments revealed the loss of enzymatic activity and the dominant-negative effect of the TNSALP[p.Gly495_Leu511del] variant; thus, the patient was diagnosed as having autosomal dominant HPP. The TNSALP[p.Gly495_Leu511del] variant was localized to the plasma membrane as was the wild-type TNSALP (TNSALP[WT]): however, co-immunoprecipitation experiments suggested a reduced dimerization between TNSALP[p.Gly495_Leu511del] and TNSALP[WT]. This case expands the variable clinical manifestation of childhood HPP and sheds light on the molecular bases underlying the dominant-negative effects of some TNSALP variants.

摘要

低磷性佝偻病(HPP)由编码组织非特异性碱性磷酸酶(TNSALP)的基因的失活变体引起。在HPP的六种亚型中,儿童期HPP在6个月至18岁之间出现,以常染色体显性和常染色体隐性两种方式遗传。儿童期HPP患者有多种症状,包括佝偻病样骨改变、低骨矿物质密度(BMD)、身材矮小、肌肉无力、颅缝早闭和乳牙过早脱落。在此,我们描述了一名患有儿童期HPP的7岁男孩,他表现出身材矮小、腕骨骨化受损和低BMD。基因检测在该基因中发现了一个新的杂合51 bp框内缺失(c.1482_1532del51),导致甘氨酸495和亮氨酸511之间缺少17个氨基酸(p.Gly495_Leu511del)。转染实验揭示了TNSALP[p.Gly495_Leu511del]变体的酶活性丧失和显性负效应;因此,该患者被诊断为患有常染色体显性HPP。TNSALP[p.Gly495_Leu511del]变体与野生型TNSALP(TNSALP[WT])一样定位于质膜;然而,免疫共沉淀实验表明TNSALP[p.Gly495_Leu511del]和TNSALP[WT]之间的二聚化减少。该病例扩展了儿童期HPP的可变临床表现,并揭示了一些TNSALP变体显性负效应的分子基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eea8/10288296/eb7c33fc1d05/cpe-32-180-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eea8/10288296/9b7d4be9d4cf/cpe-32-180-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eea8/10288296/5bb12985fee6/cpe-32-180-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eea8/10288296/eb7c33fc1d05/cpe-32-180-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eea8/10288296/9b7d4be9d4cf/cpe-32-180-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eea8/10288296/5bb12985fee6/cpe-32-180-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eea8/10288296/eb7c33fc1d05/cpe-32-180-g003.jpg

相似文献

1
A unique case of childhood hypophosphatasia caused by a novel heterozygous 51-bp in-frame deletion in the gene.一例由该基因中一个新的51个碱基对的框内杂合缺失导致的儿童低磷酸酯酶症的独特病例。
Clin Pediatr Endocrinol. 2023;32(3):180-187. doi: 10.1297/cpe.2023-0019. Epub 2023 May 6.
2
Clinical and Genetic Characteristics of Pediatric Patients with Hypophosphatasia in the Russian Population.俄罗斯人群中儿童低磷酸酯酶症患者的临床和遗传特征。
Int J Mol Sci. 2022 Oct 26;23(21):12976. doi: 10.3390/ijms232112976.
3
Two novel mutations in the ALPL gene of unrelated Chinese children with Hypophosphatasia: case reports and literature review.两例中国非亲缘性低磷酸酯酶症患儿 ALPL 基因突变:病例报告及文献复习
BMC Pediatr. 2019 Nov 25;19(1):456. doi: 10.1186/s12887-019-1800-4.
4
Molecular phenotype of tissue-nonspecific alkaline phosphatase with a proline (108) to leucine substitution associated with dominant odontohypophosphatasia.与显性牙本质发育不全相关的组织非特异性碱性磷酸酶脯氨酸(108)至亮氨酸替代的分子表型。
Mol Genet Metab. 2015 Aug;115(4):180-5. doi: 10.1016/j.ymgme.2015.05.006. Epub 2015 May 12.
5
Hypophosphatasia: An overview For 2017.低磷酸酯酶症:2017 年概述。
Bone. 2017 Sep;102:15-25. doi: 10.1016/j.bone.2017.02.011. Epub 2017 Feb 24.
6
Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients.低磷性骨软化症:基于25年173例儿科患者经验对儿童临床疾病分类学的验证与扩展
Bone. 2015 Jun;75:229-39. doi: 10.1016/j.bone.2015.02.022. Epub 2015 Feb 27.
7
Novel mutation in the ALPL gene with a dominant negative effect in a Japanese family.一个日本家族中具有显性负效应的 ALPL 基因中的新突变。
J Bone Miner Metab. 2021 Sep;39(5):804-809. doi: 10.1007/s00774-021-01219-0. Epub 2021 Apr 5.
8
Hypophosphatasia: Biochemical hallmarks validate the expanded pediatric clinical nosology.低磷酸酯酶症:生化标志物验证了扩展的儿科临床分类学。
Bone. 2018 May;110:96-106. doi: 10.1016/j.bone.2018.01.022. Epub 2018 Jan 31.
9
Genotype-Phenotype Associations in 72 Adults with Suspected ALPL-Associated Hypophosphatasia.72例疑似与碱性磷酸酶(ALPL)相关的低磷酸酯酶血症成人患者的基因型-表型关联
Calcif Tissue Int. 2021 Mar;108(3):288-301. doi: 10.1007/s00223-020-00771-7. Epub 2020 Nov 15.
10
Four novel mutations in the gene in Chinese patients with odonto, childhood, and adult hypophosphatasia.在中国牙-骨型、婴儿型和成人型低磷酸酯酶症患者中基因的四个新突变。
Biosci Rep. 2018 Aug 29;38(4). doi: 10.1042/BSR20171377. Print 2018 Aug 31.

本文引用的文献

1
Clonal osteoblastic cell lines with CRISPR/Cas9-mediated ablation of Pit1 or Pit2 show enhanced mineralization despite reduced osteogenic gene expression.经 CRISPR/Cas9 介导的 Pit1 或 Pit2 缺失的克隆成骨细胞系尽管成骨基因表达降低,但矿化能力增强。
Bone. 2021 Oct;151:116036. doi: 10.1016/j.bone.2021.116036. Epub 2021 Jun 9.
2
Large-scale in vitro functional testing and novel variant scoring via protein modeling provide insights into alkaline phosphatase activity in hypophosphatasia.通过蛋白质建模进行大规模的体外功能测试和新型变异评分,为低磷酸酶血症中碱性磷酸酶活性提供了深入的见解。
Hum Mutat. 2020 Jul;41(7):1250-1262. doi: 10.1002/humu.24010. Epub 2020 Mar 18.
3
Clinical Practice Guidelines for Hypophosphatasia.
低磷酸酯酶症临床实践指南。
Clin Pediatr Endocrinol. 2020;29(1):9-24. doi: 10.1297/cpe.29.9. Epub 2020 Jan 9.
4
Hypophosphatasia in Japan: ALPL Mutation Analysis in 98 Unrelated Patients.日本低磷酸酯酶症:98 例非相关患者的 ALPL 基因突变分析。
Calcif Tissue Int. 2020 Mar;106(3):221-231. doi: 10.1007/s00223-019-00626-w. Epub 2019 Nov 9.
5
Hypophosphatasia.低磷酸酯酶症。
Metabolism. 2018 May;82:142-155. doi: 10.1016/j.metabol.2017.08.013. Epub 2017 Sep 20.
6
Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.低磷酸酯酶症——病因学、命名法、发病机制、诊断和治疗。
Nat Rev Endocrinol. 2016 Apr;12(4):233-46. doi: 10.1038/nrendo.2016.14. Epub 2016 Feb 19.
7
Alkaline Phosphatase and Hypophosphatasia.碱性磷酸酶与低磷酸酯酶症
Calcif Tissue Int. 2016 Apr;98(4):398-416. doi: 10.1007/s00223-015-0079-1. Epub 2015 Nov 21.
8
Molecular evolution of the tissue-nonspecific alkaline phosphatase allows prediction and validation of missense mutations responsible for hypophosphatasia.组织非特异性碱性磷酸酶的分子进化有助于预测和验证导致低磷酸酯酶症的错义突变。
J Biol Chem. 2014 Aug 29;289(35):24168-79. doi: 10.1074/jbc.M114.576843. Epub 2014 Jul 14.
9
Phosphoethanolamine normal range in pediatric urines for hypophosphatasia screening.
Clin Chem Lab Med. 2012 Dec;50(12):2231-3. doi: 10.1515/cclm-2012-0266.
10
Enhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide.增强药物向骨骼的递送:对标记有酸性寡肽的人组织非特异性碱性磷酸酶的表征。
Mol Genet Metab. 2006 Jul;88(3):244-55. doi: 10.1016/j.ymgme.2006.02.012. Epub 2006 Apr 17.